The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329
Self-citationDose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
Self-citationJones, S. E., & Salmon, S. E. (1990) · Medical Entomology and Zoology · Cited by 532
Tumor size, sensitivity to therapy, and design of treatment schedules.
Norton, L., & Simon, R. M. (1977) · PubMed · Cited by 447
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Prognostic Factors in Breast Cancer.
(1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300170130053 · Cited by 343
DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER
Howard Redding, W., Monaghan, P., Imrie, S., Ormerod, M., Gazet, J.-C., Charles Coombes, R., Clink, H., Dearnaley, D., Sloane, J., Powles, T. J., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91150-9 · Cited by 263
Fisher, B., Redmond, C., Brown, A., Wickerham, D. L., Wolmark, N., Allegra, J., Escher, G., Lippman, M., Savlov, E., & Wittliff, J. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.4.227 · Cited by 260
OVARIAN FUNCTION IN PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
Rose, D. P., & Davis, T. E. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92716-7 · Cited by 150
Adjuvant systemic therapy for resectable breast cancer.
Bonadonna, G., & Valagussa, P. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.2.259 · Cited by 120
Self-citationCyclical Combination Chemotherapy for Advanced Breast Carcinoma
Canellos, G. P., DeVita, V. T., Gold, G. L., Chabner, B. A., Schein, P. S., & Young, R. C. (1974) · BMJ · doi:10.1136/bmj.1.5901.218 · Cited by 105
He, S., & Fm, S. (1984) · PubMed · Cited by 64
Glass, A. G., Wieand, H. S., Fisher, B., et al. (1981) · PubMed · Cited by 32
Cited by
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer
Budman, D. R., Berry, D. A., Cirrincione, C. T., Henderson, Wood, W. C., Weiss, R. B., Ferree, C. R., Muss, H. B., Green, M. R., Norton, L., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1205 · Cited by 577
Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast Cancer
Walshe, J. M., Denduluri, N., & Swain, S. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2793 · Cited by 354
ANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Crivellari, D., Bonetti, M., Castiglione-Gertsch, M., Gelber, R. D., Rudenstam, C.-M., Thürlimann, B., Price, K. N., Coates, A. S., Hürny, C., Bernhard, J., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1412 · Cited by 291
Metadata
- Authors
- Bonadonna, G., Valagussa, P., Rossi, A., Tancini, G., Brambilla, C., Zambetti, M., & Veronesi, U.
- Venue
- Breast Cancer Research and Treatment
- Published
- 1985-06
- Volume
- 5
- Issue
- 2
- Pages
- 95-115
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2063561065
- Cited by
- 289
- References
- 13
- FWCI
- 14.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.